Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
Resource Type
Article
Authors
Akhurst, Tim ; Alipour, Ramin ; Bailey, Dale ; Banks, Patricia ; Beaulieu, Alexis ; Campbell, Louise ; Crumbaker, Megan ; Dhiantravan, Nattakorn ; Hamid, Anis ; Haskali, Mohammad ; Hung, Terry ; Kong, Grace ; Lawrence, Nick ; Lewin, Jeremy ; McCarthy, Michael ; Moodie, Kate ; Murphy, Declan ; Nguyen, Andrew ; Pook, David ; Ravi Kumar, Aravind ; Roach, Paul ; Roselt, Peter ; Saghebi, Javad ; Schembri, Geoff ; Spain, Lavinia ; Subramaniam, Shalini ; Thang, Sue Ping ; Thomas, Paul ; Tran, Ben ; Wallace, Roslyn ; Yip, Sonia ; Hofman, Michael S ; Emmett, Louise ; Sandhu, Shahneen ; Iravani, Amir ; Buteau, James P ; Joshua, Anthony M ; Goh, Jeffrey C ; Pattison, David A ; Tan, Thean Hsiang ; Kirkwood, Ian D ; Ng, Siobhan ; Francis, Roslyn J ; Gedye, Craig ; Rutherford, Natalie K ; Weickhardt, Andrew ; Scott, Andrew M ; Lee, Sze-Ting ; Kwan, Edmond M ; Azad, Arun A ; Ramdave, Shakher ; Redfern, Andrew D ; Macdonald, William ; Guminski, Alex ; Hsiao, Edward ; Chua, Wei ; Lin, Peter ; Zhang, Alison Yan ; Stockler, Martin R ; Williams, Scott G ; Martin, Andrew J ; Davis, Ian D
Source
In The Lancet Oncology January 2024 25(1):99-107
Subject
Primary Research Articles
Language
ISSN
1470-2045